Unknown

Dataset Information

0

Binding of perlecan to transthyretin in vitro.


ABSTRACT: Transthyretin is one of two specific proteins involved in the transport of thyroid hormones in plasma; it possesses two binding sites for serum retinol-binding protein. In the present study we demonstrate that transthyretin also interacts in vitro with [35S]sulphate-labelled material from the medium of HepG2 cells. By using the same strategy as for purifying serum retinol-binding protein, [35S]sulphate-labelled medium was specifically eluted from a transthyretin-affinity column. Ion-exchange chromatography showed that the material was highly polyanionic, and its size and alkali susceptibility suggested that it was a proteoglycan. Structural analyses with chondroitinase ABC lyase and nitrous acid revealed that approx. 20% was chondroitin sulphate and 80% heparan sulphate. Immunoprecipitation showed that the [35S]sulphate-labelled material contained perlecan. Further analysis by binding studies revealed specific and saturable binding of 125I-transthyretin to perlecan-enriched Matrigel. Because inhibition of sulphation by treating HepG2 cells with sodium chlorate increased the affinity of the perlecan for transthyretin, and [3H]heparin was not retained by the transthyretin affinity column, the binding is probably mediated by the core protein and is not a protein-glycosaminoglycan interaction. Because perlecan is released from transthyretin in water, the binding might be due to hydrophobic interactions.

SUBMITTER: Smeland S 

PROVIDER: S-EPMC1218739 | biostudies-other | 1997 Sep

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC6137083 | biostudies-literature
| S-EPMC3540034 | biostudies-literature
| S-EPMC6139548 | biostudies-literature
| S-EPMC3530273 | biostudies-literature
| S-EPMC60817 | biostudies-literature
| S-EPMC9057628 | biostudies-literature
| S-EPMC4407597 | biostudies-literature
| S-EPMC1221765 | biostudies-other
| S-EPMC2978593 | biostudies-literature
| S-EPMC2951245 | biostudies-literature